Table 1.
Targets/substrates of F-box proteins and their biological functions
F-box protein | Localization | Role | Substrates | Biological functions |
---|---|---|---|---|
FBXL gene family | ||||
SKP2 | Nucleus,Cytoplasm | Oncogene | RELN | EMT 16 |
CARM1 | AMPK pathway 18 | |||
AKT (K63) | AKT Pathway 167 | |||
PDCD4 | Apoptosis 34 | |||
P21 | Cell cycle 23 | |||
P27 | Cell cycle 22 | |||
P130 | Cell cycle 27 | |||
c-Myc | Cell cycle 26 | |||
Cyclin E | Cell cycle 25 | |||
FOXO1 | FOXO signaling pathway 33 | |||
YAP1 (K63) | Transcription of target genes 35 | |||
FBXL2 | Cytoplasm, Membrane | Potential tumor suppressor | Cyclin D | Cell cycle checkpoints42, 43 |
AURKB | Cell cycle checkpoints44 | |||
p85β | PI3K pathway 7 | |||
IP3R3 | PI3K pathway 11 | |||
FOXM1 | Cell proliferation 45 | |||
FBXL3 | Nucleus, Cytoplasmic | Potential tumor suppressor | CRY1,CRY2 | Circadian clock system 49 |
c-Myc | Cell cycle progression, apoptosis and cellular transformation 50 | |||
TLK2 | Cell cycle 51 | |||
FBXL4 | Cytoplasm, Mitochondrion, Nucleus | Potential tumor suppressor | KDM4A | Replication time 52 |
RDL | Timing of sleep 53 | |||
FBXL5 | Cytoplasm, Perinuclear region | Potential tumor suppressor | IRP1,IRP2 | Iron metabolism 56 168 |
p150 | Genome stability59 | |||
SNAIL1 | EMT 60 | |||
CITED2 | HIF pathway 61 | |||
hSSB1 | DNA repair 62 | |||
FBXL7 | Cytoskeleton | Potential oncogene | AURKA | Cell cycle 63 |
Survivin | Apoptosis 65 | |||
FBXL12 | Cytoplasm, Nucleus | Unclear | ALDH3 | T cell development 70 |
Ku80 | Non homologues end joining double strand break repair mechanism 169 | |||
CaMKI | Cell cycle 68 | |||
p21 | Cell cycle progression at G1 69 | |||
FBXL13 | Cytoskeleton, Cytoplasm | Potential oncogene | CEP192 | Centrosome duplication 72 |
FBXL14 | Cytoplasm | Potential tumor suppressor | CDCP1 | Tyrosine phosphorylation-dependent regulation of cellular events 77 |
SNAIL1 | EMT 75 | |||
c-Myc | Cell cycle progression, apoptosis and cellular transformation 76 | |||
HES1 | Neuron development 78 | |||
TWIST1 | EMT 74 | |||
FBXL15 | Cytoplasm | Unclear | SMURF1 | BMP signaling pathway 12 |
FBXL17 | Nucleus, Cytoplasm | Potential oncogene | SUFU | Hedgehog signal pathway79 |
BACH1 | NRF2 oxidative stress pathway 14 | |||
FBXL18 | Cytoplasm, Nucleus | Potential oncogene | XPB | Transcription 81 |
AKT(K63) | AKT pathway 15 | |||
FBXL19 | Cytoplasm | Potential tumor suppressor | RAC3 | TGFβ1-induced E-cadherin down-regulation 83 |
RhoA | Cell proliferation and cytoskeleton rearrangement 84 | |||
FBXL20 | Cytoplasm | Potential oncogene | E-cadherin | Wnt signaling pathway 87 |
Vps34 | Autophagy 86 | |||
FBXL21 | Cytoplasm, Nucleus | Unclear | CRY1,CRY2 | Circadian clock system 88 |
FBXW gene family | ||||
β-TrCP | Nucleus, Cytoplasm | Generally oncogene & tumor suppressor in a few cases | β-catenin | Cell viability 90 |
IκBα | NF-κB pathway 93 | |||
CDC25A | Cell cycle 94 | |||
REST | Spindle check points 96 | |||
MCL1 | Anti-apoptotic (a member of the Bcl-2 family) 97 | |||
p53 | p53 pathway 101 | |||
c-Myc | Apoptosis 99 | |||
Lipin1 | Fatty acid biosynthesis 100 | |||
MTSS1 | Tumour suppression 104 | |||
NRF2 | NRF2 pathway 98 | |||
FBXW2 | β-TrCP-FBXW2-SKP2 axis 102 | |||
ZNF281 | Colorectal cancer progression 103 | |||
DEPTOR, REDD1 | Autophagy 105 | |||
FBXW7 | FBXWα: Nucleoplasm, FBXWβ: Cytoplasm, FBXWγ:Nucleolus | Tumor suppressor | Cyclin E | Cell cycle 106 |
mTOR | mTOR signaling pathway 110 | |||
NOTCH1 | NOTCH1 signaling 114 | |||
c-Jun and DEK | Closed circularity of DNA, cell cycle progression 112 | |||
MCL1 | Apoptosis 111 | |||
c-Myc | Cell proliferation 109 | |||
FBXW2 | Cytoplasm | Potential tumor suppressor | SKP2 | β-TrCP-FBXW2-SKP2 axis 102 |
β-catenin | 116 | |||
FBXW5 | Cytoplasm, Nucleus | Unclear | SASS6 | Centrosome duplication 118 |
EPS8 | Cell proliferation and motility 119 | |||
TSC2 | Tuberous sclerosis 117 | |||
FBXW8 | Golgi apparatus, Cytoplasm | Unclear | MAP4K1 | MAPK pathway 120 |
FBXO gene family | ||||
FBXO1 | Nucleus, Cytoplasm, Cytoskeleton | Potential tumor suppressor | RRM2 | DNA replication and DNA repair synthesis 122 |
CP110 | Centrosome duplication; Genomic integrity 121 | |||
NUSAP1 | Chromosome assembly 123 | |||
CDC6 | Early steps of DNA replication 124 | |||
FBXO3 | Nucleus, Cytoplasm | Unclear | AIRE | T cell development 128 |
HIPK2,p300 | Transcription 126 | |||
SMRUF1 | BMP signaling pathway 129 | |||
FBXO4 | Cytoplasm | Tumor suppressor | TRF1 | Cell cycle 131 |
MCL1 | Apoptosis 137 | |||
FXR1 | RNA binding protein and Fragile X syndrome 134 | |||
ICAM1 | Intercellular adhesion 136 | |||
PPARγ | Adipocyte differentiation 138 | |||
Cyclin D1 | Cell cycle 130 | |||
FBXO6 | Cytoplasm | Unclear | CHK1 | Cisplatin sensitivity 140 |
MAD2,BUBR1 | Spindle checkpoint 142 | |||
Ero1L | Apoptosis 141 | |||
FBXO7 | Cytoplasm, Mitochondrion, Nucleus | Potential oncogene | cIAP1 | Inhibition of apoptosis 146 |
FBXO10 | Cytoplasm | Potential tumor suppressor | BCL1 | Apoptosis 170 |
FBXO11 | Chromosome, Nucleus | Potential tumor suppressor | HIF-1α | HIF-1αsignaling pathway 143 |
BCL6 | B-cells differentiation 147 | |||
SNAIL | EMT 148 | |||
FBXO21 | Cytoplasm | Unclear | EID1 | Cell cycle 164 |
FBXO22 | Cytoplasm, Nucleus, Z disc | Unclear | ACTN2, FLNC | Contractile function 165 |
FBXO31 | Cytoplasm, Cytoskeleton | Potential tumor suppressor | SNAIL1 | EMT 153 |
Cyclin D1 | Cell cycle 152 | |||
MDM2 | p53-mediated growth arrest 154 | |||
MKK6 | MAPK pathway 155 | |||
FBXO32 | Cytoplasm, Nucleus | Unclear | KLF4 | Apoptosis 156 |
IκBα | NF-κB pathway 157 | |||
CTBP1 | EMT 158 | |||
FBXO38 | Cytoplasm, Nucleus | Potential tumor suppressor | PD-1 | Immunity of T cells 166 |
FBXO45 | Postsynaptic cell membrane , Cell junction, Synapse | Unclear | N-Cadherin | Neuronal differentiation 163 |
PAR4 | Apoptosis 161 | |||
p73 | Apoptosis 162 |
Note: other unlisted F-box proteins have no known substrates at present. The potential roles of F-box proteins, mostly context dependent, are just based on current limited studies.